ASBP: Aspire Biopharma Holdings, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | Highbridge Capital Management, LLC | 0.00% | SEC | |
| 2026-08-10 | New 13G stake | GARY SHIRINYAN | 7.70% | SEC | |
| 2026-08-06 | 13G amendment | Lance Friedman | 7.92% | SEC |
Institutional ownership (Q2 2026)
12 institutions reported holding $251K of Aspire Biopharma Holdings, Inc. on Form 13F (0 the quarter before). 12 opened a new position and 0 sold out. Shares held by institutions: new.
| Largest holders | Shares | Value |
|---|---|---|
| JANE STREET GROUP, LLC | 14,830 | $79K |
| GEODE CAPITAL MANAGEMENT, LLC | 10,474 | $56K |
| VANGUARD CAPITAL MANAGEMENT LLC | 10,408 | $56K |
| VANGUARD FIDUCIARY TRUST CO | 10,081 | $54K |
| Crewe Advisors LLC | 677 | $4K |
| Tower Research Capital LLC (TRC) | 283 | $2K |
| TORONTO DOMINION BANK | 166 | $886 |
| Crossingbridge Advisors, LLC | 20 | $107 |
| SBI Securities Co., Ltd. | 2 | $11 |
| UBS Group AG | 1 | $5 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.